Transplantation Therapeutics Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: T5819CC36B38EN
Market Monitor Global

Abstracts

Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body.

This report contains market size and forecasts of Transplantation Therapeutics Drugs in Global, including the following market information:

Global Transplantation Therapeutics Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Transplantation Therapeutics Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Calcineurin Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transplantation Therapeutics Drugs include Novartis, GlaxoSmithKline, AbbVie, Pfizer, Astellas Pharma, Gilead Sciences, SBI Biotech, Sanofi and Takeda. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transplantation Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transplantation Therapeutics Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Transplantation Therapeutics Drugs Market Segment Percentages, by Type, 2021 (%)

• Calcineurin Inhibitors
• Anti-Proliferative Agents
• Corticosteroids
• Others

Global Transplantation Therapeutics Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Transplantation Therapeutics Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Transplantation Therapeutics Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Transplantation Therapeutics Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Transplantation Therapeutics Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Transplantation Therapeutics Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• GlaxoSmithKline
• AbbVie
• Pfizer
• Astellas Pharma
• Gilead Sciences
• SBI Biotech
• Sanofi
• Takeda

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Transplantation Therapeutics Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Transplantation Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TRANSPLANTATION THERAPEUTICS DRUGS OVERALL MARKET SIZE

2.1 Global Transplantation Therapeutics Drugs Market Size: 2021 VS 2028
2.2 Global Transplantation Therapeutics Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Transplantation Therapeutics Drugs Players in Global Market
3.2 Top Global Transplantation Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Transplantation Therapeutics Drugs Revenue by Companies
3.4 Top 3 and Top 5 Transplantation Therapeutics Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Transplantation Therapeutics Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transplantation Therapeutics Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Transplantation Therapeutics Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Transplantation Therapeutics Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Transplantation Therapeutics Drugs Market Size Markets, 2021 & 2028
  4.1.2 Calcineurin Inhibitors
  4.1.3 Anti-Proliferative Agents
  4.1.4 Corticosteroids
  4.1.5 Others
4.2 By Type - Global Transplantation Therapeutics Drugs Revenue & Forecasts
  4.2.1 By Type - Global Transplantation Therapeutics Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Transplantation Therapeutics Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Transplantation Therapeutics Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Transplantation Therapeutics Drugs Revenue & Forecasts
  5.2.1 By Application - Global Transplantation Therapeutics Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Transplantation Therapeutics Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Transplantation Therapeutics Drugs Market Size, 2021 & 2028
6.2 By Region - Global Transplantation Therapeutics Drugs Revenue & Forecasts
  6.2.1 By Region - Global Transplantation Therapeutics Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Transplantation Therapeutics Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Transplantation Therapeutics Drugs Revenue, 2017-2028
  6.3.2 US Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.3.3 Canada Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.3.4 Mexico Transplantation Therapeutics Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Transplantation Therapeutics Drugs Revenue, 2017-2028
  6.4.2 Germany Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.4.3 France Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.4.4 U.K. Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.4.5 Italy Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.4.6 Russia Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.4.8 Benelux Transplantation Therapeutics Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Transplantation Therapeutics Drugs Revenue, 2017-2028
  6.5.2 China Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.5.3 Japan Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.5.4 South Korea Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.5.6 India Transplantation Therapeutics Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Transplantation Therapeutics Drugs Revenue, 2017-2028
  6.6.2 Brazil Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.6.3 Argentina Transplantation Therapeutics Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue, 2017-2028
  6.7.2 Turkey Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.7.3 Israel Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Transplantation Therapeutics Drugs Market Size, 2017-2028
  6.7.5 UAE Transplantation Therapeutics Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Transplantation Therapeutics Drugs Major Product Offerings
  7.1.4 Novartis Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Transplantation Therapeutics Drugs Major Product Offerings
  7.2.4 GlaxoSmithKline Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 AbbVie
  7.3.1 AbbVie Corporate Summary
  7.3.2 AbbVie Business Overview
  7.3.3 AbbVie Transplantation Therapeutics Drugs Major Product Offerings
  7.3.4 AbbVie Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.3.5 AbbVie Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Transplantation Therapeutics Drugs Major Product Offerings
  7.4.4 Pfizer Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Astellas Pharma
  7.5.1 Astellas Pharma Corporate Summary
  7.5.2 Astellas Pharma Business Overview
  7.5.3 Astellas Pharma Transplantation Therapeutics Drugs Major Product Offerings
  7.5.4 Astellas Pharma Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.5.5 Astellas Pharma Key News
7.6 Gilead Sciences
  7.6.1 Gilead Sciences Corporate Summary
  7.6.2 Gilead Sciences Business Overview
  7.6.3 Gilead Sciences Transplantation Therapeutics Drugs Major Product Offerings
  7.6.4 Gilead Sciences Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.6.5 Gilead Sciences Key News
7.7 SBI Biotech
  7.7.1 SBI Biotech Corporate Summary
  7.7.2 SBI Biotech Business Overview
  7.7.3 SBI Biotech Transplantation Therapeutics Drugs Major Product Offerings
  7.7.4 SBI Biotech Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.7.5 SBI Biotech Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Transplantation Therapeutics Drugs Major Product Offerings
  7.8.4 Sanofi Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News
7.9 Takeda
  7.9.1 Takeda Corporate Summary
  7.9.2 Takeda Business Overview
  7.9.3 Takeda Transplantation Therapeutics Drugs Major Product Offerings
  7.9.4 Takeda Transplantation Therapeutics Drugs Revenue in Global Market (2017-2022)
  7.9.5 Takeda Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Transplantation Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 2. Transplantation Therapeutics Drugs Market Drivers in Global Market
Table 3. Transplantation Therapeutics Drugs Market Restraints in Global Market
Table 4. Key Players of Transplantation Therapeutics Drugs in Global Market
Table 5. Top Transplantation Therapeutics Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Transplantation Therapeutics Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Transplantation Therapeutics Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Transplantation Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Transplantation Therapeutics Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transplantation Therapeutics Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Transplantation Therapeutics Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Transplantation Therapeutics Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Transplantation Therapeutics Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Transplantation Therapeutics Drugs Product Offerings
Table 32. Novartis Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Transplantation Therapeutics Drugs Product Offerings
Table 35. GlaxoSmithKline Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 36. AbbVie Corporate Summary
Table 37. AbbVie Transplantation Therapeutics Drugs Product Offerings
Table 38. AbbVie Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Transplantation Therapeutics Drugs Product Offerings
Table 41. Pfizer Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Astellas Pharma Corporate Summary
Table 43. Astellas Pharma Transplantation Therapeutics Drugs Product Offerings
Table 44. Astellas Pharma Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Sciences Corporate Summary
Table 46. Gilead Sciences Transplantation Therapeutics Drugs Product Offerings
Table 47. Gilead Sciences Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 48. SBI Biotech Corporate Summary
Table 49. SBI Biotech Transplantation Therapeutics Drugs Product Offerings
Table 50. SBI Biotech Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Transplantation Therapeutics Drugs Product Offerings
Table 53. Sanofi Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Takeda Corporate Summary
Table 55. Takeda Transplantation Therapeutics Drugs Product Offerings
Table 56. Takeda Transplantation Therapeutics Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Transplantation Therapeutics Drugs Segment by Type in 2021
Figure 2. Transplantation Therapeutics Drugs Segment by Application in 2021
Figure 3. Global Transplantation Therapeutics Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Transplantation Therapeutics Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Transplantation Therapeutics Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transplantation Therapeutics Drugs Revenue in 2021
Figure 8. By Type - Global Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 12. US Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 24. China Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Transplantation Therapeutics Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Transplantation Therapeutics Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AbbVie Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Astellas Pharma Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead Sciences Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. SBI Biotech Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda Transplantation Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)